ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ASXC Asensus Surgical Inc

0.267
0.0146 (5.78%)
Last Updated: 14:32:22
Delayed by 15 minutes
Share Name Share Symbol Market Type
Asensus Surgical Inc AMEX:ASXC AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.0146 5.78% 0.267 0.267 0.26 0.26 65,740 14:32:22

Asensus Surgical to Participate in the H.C. Wainwright 25th Annual Global Investment Conference and 2023 Cantor Global Healthcare Conference

05/09/2023 11:55am

GlobeNewswire Inc.


Asensus Surgical (AMEX:ASXC)
Historical Stock Chart


From May 2023 to May 2024

Click Here for more Asensus Surgical Charts.

Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H.C. Wainwright 25th Annual Global Investment Conference. The Company’s fireside chat will take place on Monday, September 11, 2023 at 3:00 pm Eastern Time.

In addition, the Company will participate in the 2023 Cantor Global Healthcare Conference. The Company’s fireside chat will take place on Tuesday, September 26, 2023 at 4:20 pm Eastern Time.

Each of the conference webcasts will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations. Replays of the webcasts will be archived on the website for approximately 90 days.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. Based upon the foundations of Digital Laparoscopy and the Senhance® Surgical System, the Company is developing the LUNA™ Surgical System, a next generation robotic and instrument system as a foundation of its Digital Surgery solution. These systems will be powered by the Intelligent Surgical Unit to increase surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. The Senhance Surgical System is now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. To learn more about Performance-Guided Surgery, Digital Laparoscopy with the Senhance Surgical System and the new LUNA System visit www.asensus.com.

Follow Asensus:

Email Alerts: https://ir.asensus.com/email-alertsLinkedIn: https://www.linkedin.com/company/asensus-surgical-incTwitter: https://twitter.com/AsensusSurgicalYouTube: https://www.youtube.com/@AsensusSurgicalVimeo: https://vimeo.com/asxcTikTok: https://www.tiktok.com/@asensus_surgical

INVESTOR CONTACT:Mark Klausner or Mike VallieICR Westwickeinvest@asensus.com443-213-0499

MEDIA CONTACT:Dan VentrescaMatter CommunicationsAsensusPR@matternow.com617-874-5488

1 Year Asensus Surgical Chart

1 Year Asensus Surgical Chart

1 Month Asensus Surgical Chart

1 Month Asensus Surgical Chart

Your Recent History

Delayed Upgrade Clock